← Leaderboards
Christopher Eugene Dandoy
Cincinnati Childrens Hosp Med Ctr
$2,952,106
Attributed
$2,952,106
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $539K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,952,106 · 4
By mechanism
UH3$2,064,644 · 1
UG3$490,242 · 1
R21$375,220 · 1
R13$22,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventMortalityInjuryInfectionImproved OutcomeOralTransplant RecipientsPreventionPositioning AttributeRandomizedPhysiciansBacteriaPreservationMucous MembraneClinically RelevantAdmission ActivityChildhoodInnovationAdherenceMorbidity - Disease RateMucositisClinical TrialsOral CareOral Bacteria
Grant awards (8)
Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitol$518,153
UH3 · FY2025 · DE · contact PI
Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitol$516,967
UH3 · FY2024 · DE · contact PI
The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant$22,000
R13 · FY2024 · HL · contact PI
Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitol$514,925
UH3 · FY2023 · DE · contact PI
Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitol$514,599
UH3 · FY2022 · DE · contact PI
Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized, multicenter, double-blind, placebo-controlled study evaluating twice daily oral xylitol$490,242
UG3 · FY2021 · DE · contact PI
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics$167,725
R21 · FY2019 · CA · contact PI
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics$207,495
R21 · FY2018 · CA · contact PI